We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$41.7M
DM
2
Deerfield Management
New York
$37.1M +$3.74M +214,985 +11%
SI
3
Sofinnova Investments
California
$34.6M
RCM
4
RA Capital Management
Massachusetts
$34.1M
NHAS
5
Novo Holdings A/S
Denmark
$31.8M -$1.77M -101,673 -5%
PBPIA
6
Pivotal bioVenture Partners Investment Advisor
California
$27.1M
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$22M +$3.46M +199,000 +18%
CA
8
CHI Advisors
New York
$15.8M
BlackRock
9
BlackRock
New York
$15.3M +$664K +38,190 +4%
RSCM
10
Rock Springs Capital Management
Maryland
$14.3M +$215K +12,372 +1%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$12.4M +$4.56M +261,937 +56%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$10.4M
SCM
13
Suvretta Capital Management
New York
$6.22M +$413K +23,745 +7%
Vanguard Group
14
Vanguard Group
Pennsylvania
$5.71M -$98.8K -5,678 -2%
BCM
15
Burrage Capital Management
Massachusetts
$4.13M +$1.27M +73,044 +43%
O
16
OrbiMed
New York
$3.22M +$3.28M +188,704 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.06M +$510K +29,311 +19%
Citadel Advisors
18
Citadel Advisors
Florida
$2.92M -$1.21M -69,335 -29%
State Street
19
State Street
Massachusetts
$2.9M +$655K +37,670 +28%
Northern Trust
20
Northern Trust
Illinois
$2.06M +$91.8K +5,274 +5%
BBA
21
Baker Bros. Advisors
New York
$1.82M
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$1.12M
Charles Schwab
23
Charles Schwab
California
$1.06M +$42.1K +2,422 +4%
Millennium Management
24
Millennium Management
New York
$1.04M -$1.53M -87,892 -59%
Nuveen
25
Nuveen
North Carolina
$808K +$454K +26,102 +123%